Connect with us

Technology

CARESYNTAX ANNOUNCES 2024 HIGHLIGHTS

Published

on

 Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery

SAN FRANCISCO and BERLIN, Dec. 23, 2024 /PRNewswire/ — Caresyntax, the leading vendor of data-driven surgical intelligence solutions to make surgery safer and smarter, today announced its highlights and achievements of 2024. The company achieved top line 2024 organic revenue growth over 50%, with its technology and services platform used in over 4,000 ORs across the world. Due to increasing commercial velocity in the US and EU hospital markets, and expansion into new geographies and industry verticals, the company was recognized with multiple industry awards including selection to the Fierce 15 most innovative companies and the 2024 German AI prize. The company also completed a $180 million fundraise to fuel this explosive top and bottom-line growth. The company forecasts continued velocity into 2025 with focus on scale, and operational deployment, and worldwide expansion.

Continued growth in core business lines: Integrated OR and Connected Surgery
Building upon its established footprint in Europe, Caresyntax further cemented its position as the leader in surgical intelligence and OR-integration solutions with new business awards in France (Nantes, Lyon), Germany (Berlin, Hamburg), Spain (Tenerife), and Switzerland (Fribourg, Morges), alongside expansion within its existing network of hospital partners. In addition to commercial revenue, these commercial partnerships also expanded the Caresyntax portfolio to include software, services, and Internet of Things (IoT) functionalities.

In the Americas, Caresyntax continued the commercial rollout of its advanced OR Integration Connected Surgery offering, inking deals with two different large hospital systems in Florida, along with hospitals in Mexico (Mexico City, Oaxaca, Campeche), and Chile (Santiago). The market has shown great interest in Connected Surgery’s benefits: a lightweight footprint, vendor-neutrality, cost-effectiveness compared to traditional OR integration, and future-proof capability for continuous evolution and updates through a cloud-based architecture. In addition to new hospital placements, the company also focused on value delivery and expansion within its flagship customers in the US, signing expansion deals for its OR analytics, OR scheduling, Video-Based Assessment, OR workflow, and Clinical Value Assessment solutions with key customers including Universal Health Services (UHS), the OSF Healthcare, the Ascension Health Alliance, and the University of Iowa.

New CDaaS offering for medtech partners: rapid adoption and uptake from industry
Launched at the J.P. Morgan Healthcare Conference in January 2024, Caresyntax completed the development and deployment of the Clinical Data as a Service (CDaaS) portfolio for medtech partners. Building upon decades of thought leadership by the company’s Chief Medical Informatics Officer, Bruce Ramshaw, MD, the company integrated his team’s continuous quality improvement methodology, advanced systems science, and user-friendly dashboard analytics into the Caresyntax platform. The key differentiators of the Caresyntax data collection platform include flexibility (no strict protocols, IRB, or patient consent), data accuracy (data ingestion, curation, and cleansing), and speed (data for publication within months, compared to years.) Most importantly, CDaaS offerings can be tailored around existing clinical evidence strategy, wrapping around trial sites or collecting data from entirely different clinical sites.
In its first year on the market, the portfolio developed into a multi-million-dollar business with win rates well above traditional SaaS business models (Caresyntax win rate above 40%), tremendous market upside (7 new partnerships signed in Q3 and Q4), outstanding retention rates (3 existing customers inked expansion or renewal), and annual revenue growth projected above 100%. In 2024, CDaaS data was used for 10 abstracts or poster presentations, 2 society presentations, 2 published manuscripts, and 1 FDA indication expansion. Caresyntax has signed deals with medtech customers across all surgical specialties, with interest from the complete range of partner sizes, from early-stage startups to multinational strategic players.

Leveraging Strategic Collaborations and Key Partnerships
In addition to its direct-to-customer activities, Caresyntax also established key partnerships that provide accretive revenue and additional avenues for commercial success. The company expanded its partnership with D-Scope technologies to co-develop data analysis tools and advanced reporting capabilities for use in public, private, Veterans Administration, and Department of Defense Hospitals. The company also inked a partnership with surgical startup Qaelon to create a decentralized registry for real world data, with the aspirational goal to update the standard of care for surgical leak detection. And most recently, the company signed an initial deal with the American Hernia Society to create the backend infrastructure and frontend data visualization platform for all its members. These partnerships show promise as multiplier opportunities for expansion and cross-sell of core Caresyntax platform capabilities further downstream.

Product Innovation
In 2024, Caresyntax furthered its application of AI in the operating room to transform healthcare. By integrating AI at critical points in surgical workflows, Caresyntax helped customers enhance efficiency, reduce errors, and unlock valuable insights from previously unusable data sources.

To assist with OR scheduling and throughput, Caresyntax introduced its Block Marketplace module across 25 hospitals and 670 practices nationwide.  Block Marketplace proactively identifies potential scheduling conflicts and resource availability issues, optimizes utilization, adapts to real-time demands, and serves as a marketplace for open surgery time, maximizing prime-time utilization of the operating room.

With the launch of Connected Surgery, Caresyntax introduced supervised machine learning algorithms to help surgical leaders with operational efficiency measures throughout the surgical suite: reducing turnover time, improving compliance with the surgical safety checklist, and identifying operational bottlenecks. Caresyntax also rolled out a new Turn-by-Turn Guidance module to help clinical teams navigate and prepare for different phases of surgery.

Core to all its product offerings are the diverse data flows coming out of the varied systems of the hospital. This year, the company launched several new capabilities to capture and curate diverse multimodal data, leveraging the functionality of Generative AI and Large Language Models (LLMs). With these evolving models, the company can make more use of complex and variable unstructured sources like surgical notes and medical records to inform better algorithms and products.

Significant Momentum and Focus on Data Streams in 2025
Carrying forward this significant momentum from 2024, the company is excited to continue its growth trajectory across the Americas, Europe, and the Middle East in 2025. In addition to its expanding list of clinical sites, the company is especially excited to harness the power of its growing database of data sourced directly from the OR environment. The Caresyntax platform captures unparalleled data from the surgical continuum, including pathway decisions, in-room video, surgical and endoscopic tower feeds, clinical and financial outcomes, supply chain and cost information, and pre- and post-operative patient information.  As the company expands its footprint of OR Integration and medtech customers, those integrations contribute to create the most rich, differentiated dataset available from the surgical environment. Throughout 2025, the company plans to expend significant R&D capacity on its proprietary data analytics engine, to drive unique and novel insights for clinical, administrative, regulatory, and commercial partners downstream.

About Caresyntax
Caresyntax is on a mission to make surgery smarter and safer by converging AI-powered software, devices, and clinical services to help customers improve surgical outcomes. Our vendor neutral, enterprise-grade surgical intelligence platform delivers actionable insights to improve patient outcomes by using proprietary software and artificial intelligence (AI) to analyze large volumes of video, audio, images, device data, clinical and operational data in and around the OR. This real-world evidence can be used by the care team live, during a procedure, and accessed by those outside the operating room via the platform’s dedicated telehealth link. After a procedure, the Caresyntax platform provides insights that help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. Headquartered in San Francisco in the US and internationally in Berlin, Caresyntax software is used in more than 3,000 operating rooms worldwide and supports surgical teams in more than three million procedures per year. For more information, visit Caresyntax.com

Caresyntax Contact:
info@caresyntax.com

US Media Contact:
info@caresyntax.com

International Media Contact:
Gargee Kashyap
Senior Marketing Manager
Gargee.kashyap@caresyntax.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/caresyntax-announces-2024-highlights-302338460.html

SOURCE Caresyntax

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Real-World Study of Over 185,000 Users Finds Engagement with UpLife Digital Mental Health App Yields Significant Reductions in Depression and Anxiety

Published

on

By

Five-year evaluation shows a clear “dose–response” link between deeper engagement with UpLife’s CBT-based ‘Journeys’ programs and greater depression and anxiety symptom improvement

LEESBURG, Va., July 21, 2026 /PRNewswire-PRWeb/ — UpLife Inc, a digital mental health and self-therapy platform, today announced a set of research findings from a large real-world evaluation of its app, showing that people who engaged with the platform reported statistically significant reductions in symptoms of depression and anxiety over time. The evaluation drew on five years of real-world data from an engaged user base of more than 185,000 people across the United States and 197 other countries worldwide.

“These results reflect what we hear from users every day, now backed by data at real-world scale. What stands out is the dose–response signal where the people who lean into the work by completing their Journeys and doing the exercises are the ones who get the most out of it.” Jeff Musa, CEO, UpLife

The research analysis examined anonymized data collected between 2021 and 2026 using three validated clinical outcome measures: the PHQ-9 (depression), the GAD-7 (anxiety), and the WHO-5 (well-being). Among UpLife users who completed assessments at baseline and follow-up, depression and anxiety scores decreased significantly over time.

In the fully adjusted analysis, average depression scores (PHQ-9) fell by approximately 3.7 points; moving the typical UpLife user from the “moderately severe” range toward the “moderate” range. Anxiety scores (GAD-7) showed comparable significant reductions over time.

A clear dose–response relationship

One of the study’s central findings was a consistent dose–response pattern regarding the relationship between engagement and outcomes. Users who completed UpLife’s CBT-based ‘Journeys’ experienced a reduction in their symptoms. The study also found that the completion of additional Journeys were associated with a further measurable decrease in their assessment scores, even after accounting for subscription type and other factors. Notably, depth of engagement with therapeutic content was a stronger predictor of improvement than simply the amount of time spent in the app.

“These results reflect what we hear from users every day, now backed by data at real-world scale. What stands out most is the dose–response signal where the people who lean into the work by completing their Journeys and doing the exercises are the ones who get the most out of it. That tells us our job is to keep building an experience that helps people stay engaged, because engagement is where the clinical value lives.” — Jeff Musa, Chief Executive Officer, UpLife

Built on cognitive behavioral therapy

UpLife delivers evidence-based psychological education and interventions grounded in the principles of cognitive behavioral therapy (CBT) through five core features: structured Journeys, a Daily Plan, a Mood Tracker, journaling, and an AI assistant (“Lila”) that recommends relevant content from the platform. The app does not provide AI-generated therapy; its assistant only directs users to content that has been created, curated, and reviewed by clinicians.

For clinicians, UpLife also offers a HIPAA-compliant therapist portal that supports a Blended Care model, allowing providers to extend therapeutic support between sessions through structured digital programs, progress tracking, and shared assessments.

The platform has also been extensively used in humanitarian settings. Through UpLife’s Ukraine Humanitarian Gift Program, tens of thousands of users in Ukraine have received full, free access to a localized version of the app through UpLife’s Ukraine Humanitarian Gift Program.

About the evaluation

The study used an observational pre–post design based on real-world data and was conducted in accordance with the ethical principles of the Declaration of Helsinki. As an observational evaluation without a control group, it demonstrates associations between app engagement and symptom improvement rather than establishing causation, and well-being scores (WHO-5) did not change significantly over the study period. The findings add to a growing body of research suggesting that CBT-based digital interventions can be associated with meaningful symptom reduction, while underscoring the central role of sustained user engagement.

About UpLife

Founded in 2019, UpLife is a digital mental health and self-guided therapy platform that is designed to help people improve their emotional well-being, build healthier thinking patterns, and develop positive daily habits through structured, evidence-based psychological programs. UpLife also provides a secure, HIPAA-compliant portal to help therapists and health systems to extend care beyond the through a Blended Care Therapy model. Learn more at www.uplifecare.com.

Media Contact

Matt Landry, UpLife, 1 617-699-7205, matt@thesecondrow.net, https://www.uplifecare.com/ 

View original content:https://www.prweb.com/releases/real-world-study-of-over-185-000-users-finds-engagement-with-uplife-digital-mental-health-app-yields-significant-reductions-in-depression-and-anxiety-302829280.html

SOURCE UpLife

Continue Reading

Technology

TruHeight Joins Nordstrom and JCPenney Marketplaces as Wellness Brands Reshape the Department Store

Published

on

By

Family nutrition brand’s newest retail partnerships reflect a broader shift: health and wellness products are becoming a staple of platforms once reserved for fashion and apparel

LAS VEGAS, July 21, 2026 /PRNewswire/ — TruHeight, the family nutrition brand, today announced it is joining the Nordstrom Marketplace and the JCPenney Marketplace, bringing its lineup of clean-label vitamins, gummies, protein shakes, and everyday nutrition products to two of America’s most iconic department store names.

The partnerships place TruHeight at the center of one of retail’s most notable shifts. Department stores and fashion-first marketplaces, long defined by clothing, shoes, and accessories, are rapidly expanding into health and wellness as consumers increasingly treat wellness as part of their everyday lifestyle rather than a separate shopping trip. For a generation of shoppers, the same platforms where they buy back-to-school outfits and activewear are becoming destinations for the products that fuel those activities.

“Five years ago, you wouldn’t expect to find a family nutrition brand next to denim and sneakers,” said Justin Rapoport, Co-CEO of TruHeight. “Today, wellness is part of how families shop for everything. Nordstrom and JCPenney recognize that, and we’re proud to bring family nutrition to their marketplaces.”

The move extends a period of rapid retail growth for TruHeight, which launched in 5,000 CVS stores nationwide in June following its national debut at Target earlier this year, and is also available at iHerb and on Amazon. With the addition of Nordstrom and JCPenney, TruHeight’s products will reach shoppers across drug, mass, e-commerce, and department store channels.

“Every retailer we add is a signal of the trust families place in our brand,” said Eden Stelmach, Co-Founder of TruHeight. “Department stores are where families have shopped together for generations. Meeting them there with simple, clean nutrition products is a natural next step.”

TruHeight products will be available on the Nordstrom and JCPenney marketplaces in the coming weeks, joining the brand’s existing availability at CVS, Target, iHerb, Amazon, and truheightvitamins.com.

About TruHeight
TruHeight is a family nutrition brand offering clean-label vitamins, gummies, protein shakes, and everyday nutrition products for kids, teens, and active families. Founded with a commitment to simple ingredients and convenient formats, TruHeight products are available at major retailers nationwide and online at truheightvitamins.com.

Media Contact
TruHeight Vitamins
Kim Brown
419189@email4pr.com
4704265920
truheightvitamins.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/truheight-joins-nordstrom-and-jcpenney-marketplaces-as-wellness-brands-reshape-the-department-store-302830436.html

SOURCE TruHeight Vitamins

Continue Reading

Technology

TrendyMinds Founder Trevor Yager Returns as CEO to Lead Agency’s Next Phase of Growth

Published

on

By

Veteran agency leader returns to accelerate TrendyMinds’ AI capabilities and advance the firm’s evolution as a strategic partner helping organizations drive growth, strengthen reputation, and navigate transformation.

INDIANAPOLIS, July 21, 2026 /PRNewswire/ — Trevor Yager has returned as Chief Executive Officer (CEO) of TrendyMinds, the Indianapolis-based agency he founded in 1995, while continuing to serve as Chairman. In this dual role, Yager has resumed direct involvement in day-to-day leadership, working alongside account and delivery teams on client work in addition to setting the agency’s strategic direction. As CEO, he is leading the company’s next phase of growth by advancing the firm’s artificial intelligence (AI) capabilities while strengthening its position as a strategic partner to organizations navigating growth and change.

Yager previously transitioned from CEO to Chairman as part of a planned leadership evolution that reflected both the agency’s maturity and his own exploration of future ownership opportunities. As AI has accelerated the pace of change across the industry, reshaping how organizations operate and compete, he made the decision to step back into the CEO role and lead TrendyMinds through its next chapter directly.

“Moving into the Chairman role was the right decision at the time because the Board, including myself, believed TrendyMinds needed to demonstrate it could thrive beyond its founder,” said Yager. “But after more than 30 years of leading through every major technology shift, I believe artificial intelligence represents one of the greatest opportunities our industry has ever seen. The environment shifted fast enough that it made sense for me to step back in and lead it personally, continuing to build the capabilities our clients will need and position the agency for what’s next.”

Beginning in 2019, TrendyMinds became increasingly intentional about optimizing the artificial intelligence, machine learning, and automation capabilities already embedded within the technologies used across the agency. Following a comprehensive assessment of AI-enabled tools and workflows, the agency integrated AI across strategy, research, creative development, marketing operations, and internal business processes while establishing governance, security, and data protection standards to support responsible implementation.

By transforming its own business first, TrendyMinds refined its methodologies, validated new approaches, and built the operational discipline that now informs how it evaluates AI opportunities with clients. Today, TrendyMinds continues to expand its internal AI capabilities through a dedicated team of AI transformation specialists, developing proprietary workflows, audience intelligence tools, and implementation frameworks. Drawing on that experience, the agency helps clients responsibly evaluate and implement AI in ways that align with their business objectives, regulatory requirements, and governance standards.

That experience also enables TrendyMinds to support clients developing innovative AI technologies, including a leading healthcare AI innovator. By combining firsthand AI transformation experience with strategic consulting, communications, and market positioning expertise, the agency helps organizations communicate complex technologies, build trust with stakeholders, and accelerate market adoption.

Founded as a traditional marketing agency more than 30 years ago, TrendyMinds has continually evolved alongside the changing needs of its clients, bringing together strategic consulting, integrated marketing, communications, creative, thought leadership, media relations, digital strategy and development, research, analytics, and emerging technologies.

About TrendyMinds

TrendyMinds is the Agency of Preference®, a multidisciplinary consulting partner helping organizations accelerate growth, strengthen and protect reputation, and navigate transformation. Founded in Indianapolis in 1995, the firm has spent more than 30 years uniting strategic consulting, communications, marketing, creative, technology, and data-driven insight into a single integrated practice built to solve complex business challenges.

Learn more at TrendyMinds.com.

Media Contact:
Claire Gregory
419095@email4pr.com | 317.902.6973

View original content to download multimedia:https://www.prnewswire.com/news-releases/trendyminds-founder-trevor-yager-returns-as-ceo-to-lead-agencys-next-phase-of-growth-302830444.html

SOURCE TrendyMinds

Continue Reading

Trending